{"id":3722,"date":"2019-09-23T06:30:00","date_gmt":"2019-09-23T06:30:00","guid":{"rendered":"http:\/\/www.irlab.se\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/"},"modified":"2019-09-23T06:30:00","modified_gmt":"2019-09-23T06:30:00","slug":"irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/","title":{"rendered":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019"},"content":{"rendered":"<p><span>Kongressen &rsquo;International Congress of Parkinson&rsquo;s Disease and Movement Disorders&rsquo; 2019 h&aring;lls den 22&ndash;26 september och syftar till att uppmuntra spridning av id&eacute;er mellan de som &auml;r involverade inom v&aring;rd och forskning om r&ouml;relserelaterade sjukdomar f&ouml;r att fr&auml;mja framsteg inom b&aring;de klinik och vetenskap. Kongressen v&auml;nder sig till kliniskt verksamma l&auml;kare, forskare, sjukv&aring;rdspersonal, post-doktorer, och l&auml;karstudenter med intresse f&ouml;r den aktuella forskningen och metoder f&ouml;r diagnos och behandling av r&ouml;relserelaterade sjukdomar.<\/span><\/p>\n<p><span>Nicholas Waters, VD p&aring; IRLAB, kommenterade &rdquo;Professor Svenningsson &auml;r en enast&aring;ende forskare och vi &auml;r glada &ouml;ver att ha ett n&auml;ra samarbete med honom. Det &auml;r fantastiskt att f&aring; denna typ av erk&auml;nnande i den medicinska sf&auml;ren och det &auml;r ett privilegium att bli utvald att presentera vid kongressen, vilket ocks&aring; inneb&auml;r att v&aring;r data f&aring;ngade kongressutskottets intresse bland m&aring;nga andra inskickade abstrakt.&rdquo;<\/span><\/p>\n<p><span>F&ouml;r att hitta posterpresentationen:<\/span><\/p>\n<p><span>Abstraktets nummer: 209<\/span><\/p>\n<p><span>Abstraktets titel: &lsquo;A phase IIa trial studying the safety and tolerability of IRL752 in patients with Parkinson&rsquo;s disease dementia&rsquo;<\/span><\/p>\n<p><span>Postersessionens &auml;mne: Kliniska pr&ouml;vningar, farmakologi och behandling<\/span><\/p>\n<p><span>Presentationsdatum: m&aring;ndag 23 september<\/span><\/p>\n<p><span>Presentationstid: 13:45 &#8211; 15:15<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB meddelade idag att professor Per Svenningsson, f\u00f6r IRLAB:s r\u00e4kning, kommer att presentera en poster med titeln \u201dA phase IIa trial studying the safety and tolerability pf IRL752 in patients with Parkinson\u2019s disease dementia\u201d p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 i Nice, Frankrike. Presentationen kommer att h\u00e5llas m\u00e5ndag den 23 september.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-3722","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelade idag att professor Per Svenningsson, f\u00f6r IRLAB:s r\u00e4kning, kommer att presentera en poster med titeln \u201dA phase IIa trial studying the safety and tolerability pf IRL752 in patients with Parkinson\u2019s disease dementia\u201d p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 i Nice, Frankrike. Presentationen kommer att h\u00e5llas m\u00e5ndag den 23 september.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-23T06:30:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019\",\"datePublished\":\"2019-09-23T06:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\"},\"wordCount\":252,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\",\"name\":\"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2019-09-23T06:30:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB","og_description":"IRLAB meddelade idag att professor Per Svenningsson, f\u00f6r IRLAB:s r\u00e4kning, kommer att presentera en poster med titeln \u201dA phase IIa trial studying the safety and tolerability pf IRL752 in patients with Parkinson\u2019s disease dementia\u201d p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 i Nice, Frankrike. Presentationen kommer att h\u00e5llas m\u00e5ndag den 23 september.","og_url":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/","og_site_name":"IRLAB","article_published_time":"2019-09-23T06:30:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/"},"author":{"name":"","@id":""},"headline":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019","datePublished":"2019-09-23T06:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/"},"wordCount":252,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/","url":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/","name":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2019-09-23T06:30:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlab-presenterar-pa-2019-ars-international-congress-of-parkinsons-disease-and-movement-disorders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB presenterar p\u00e5 2019 \u00e5rs \u2019International Congress of Parkinson\u2019s Disease and Movement Disorders\u2019"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/3722","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=3722"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/3722\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=3722"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=3722"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=3722"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}